1016973

Vivex Biologics, Inc. — FEI 1000113913

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 6, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Miami, FL (United States)

Citations

IDCFRDescription
1232521 CFR 1271.160(b)(6)Deviations--evaluation, cause, corrective action
1237321 CFR 1271.200(d)Inspected routinely
1238721 CFR 1271.220(a)Causing contamination, increasing risks
1239821 CFR 1271.230(a)Validation & approval--established procedures